Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.
Saved in:
| Title: | Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis. |
|---|---|
| Authors: | Amoriello R; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy., Rizzo R; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Mariottini A; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy., Bortolotti D; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Gentili V; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Bonechi E; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy., Aldinucci A; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy., Carnasciali A; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy., Peruzzi B; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy., Repice AM; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy., Massacesi L; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department Neurology II, Careggi University Hospital, Florence, Italy., Fainardi E; Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy., Ballerini C; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy. |
| Source: | Frontiers in neurology [Front Neurol] 2022 May 25; Vol. 13, pp. 872396. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35693002 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Amoriello+R%22">Amoriello R</searchLink>; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+R%22">Rizzo R</searchLink>; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Mariottini+A%22">Mariottini A</searchLink>; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Bortolotti+D%22">Bortolotti D</searchLink>; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Gentili+V%22">Gentili V</searchLink>; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Bonechi+E%22">Bonechi E</searchLink>; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Aldinucci+A%22">Aldinucci A</searchLink>; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Carnasciali+A%22">Carnasciali A</searchLink>; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Peruzzi+B%22">Peruzzi B</searchLink>; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Repice+AM%22">Repice AM</searchLink>; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Massacesi+L%22">Massacesi L</searchLink>; Department of Neurosciences, Drugs and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department Neurology II, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Fainardi+E%22">Fainardi E</searchLink>; Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Ballerini+C%22">Ballerini C</searchLink>; Department of Clinical and Experimental Medicine (DMSC), University of Florence, Florence, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101546899%22">Frontiers in neurology</searchLink> [Front Neurol] 2022 May 25; Vol. 13, pp. 872396. <i>Date of Electronic Publication: </i>2022 May 25 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101546899 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2295 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642295%22">16642295 </searchLink><i>NLM ISO Abbreviation: </i>Front Neurol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35693002 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fneur.2022.872396 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 872396 Titles: – TitleFull: Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Amoriello R – PersonEntity: Name: NameFull: Rizzo R – PersonEntity: Name: NameFull: Mariottini A – PersonEntity: Name: NameFull: Bortolotti D – PersonEntity: Name: NameFull: Gentili V – PersonEntity: Name: NameFull: Bonechi E – PersonEntity: Name: NameFull: Aldinucci A – PersonEntity: Name: NameFull: Carnasciali A – PersonEntity: Name: NameFull: Peruzzi B – PersonEntity: Name: NameFull: Repice AM – PersonEntity: Name: NameFull: Massacesi L – PersonEntity: Name: NameFull: Fainardi E – PersonEntity: Name: NameFull: Ballerini C IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 05 Text: 2022 May 25 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1664-2295 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in neurology Type: main |
| ResultId | 1 |